Charity D. Scripture
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 8
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 2
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- William Douglas Figg (10 shared papers)Alex Sparreboom (8 shared papers)John A. Pieper (1 shared paper)Michael Hawkins (2 shared papers)Neil P. Desai (2 shared papers)Andrew Jihoon Yang (1 shared paper)Tapas Kumar De (1 shared paper)Vuong N. Trieu (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Clinical Cancer Research (3 papers)Expert Opinion on Drug Metabolism & Toxicology (1 paper)Lung Cancer (1 paper)Clinical Pharmacokinetics (1 paper)
- Partner nations
- United StatesJapanNetherlands
In The Last Decade
Charity D. Scripture
18 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 117
- Oncology 639
- Biomaterials 327
- Pharmacology 187
- Pharmaceutical Science 79
- Geriatrics and Gerontology 39
Countries citing papers authored by Charity D. Scripture
This map shows the geographic impact of Charity D. Scripture's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charity D. Scripture with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charity D. Scripture more than expected).
Fields of papers citing papers by Charity D. Scripture
This network shows the impact of papers produced by Charity D. Scripture. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charity D. Scripture. The network helps show where Charity D. Scripture may publish in the future.
Co-authors
The 25 scholars most cited alongside Charity D. Scripture, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 440 | |
| 2 | 2006 | 300 | |
| 3 | 2006 | 264 | |
| 4 | 2008 | 203 | |
| 5 | 2008 | 153 | |
| 6 | 2001 | 145 | |
| 7 | 2005 | 107 | |
| 8 | 2006 | 80 | |
| 9 | 2005 | 66 | |
| 10 | 2024 | 32 | |
| 11 | 2019 | 26 | |
| 12 | 2005 | 22 | |
| 13 | 2004 | 17 | |
| 14 | 2005 | 11 | |
| 15 | 2005 | 8 | |
| 16 | 2006 | 6 | |
| 17 | 2017 | 2 | |
| 18 | 2017 | 1 | |
| 19 | 2018 | 0 |
About Charity D. Scripture
Charity D. Scripture is a scholar working on Oncology, Pharmacology, Hematology, Pulmonary and Respiratory Medicine and Physical and Theoretical Chemistry, having authored 19 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Lung Cancer Research Studies (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Glycosylation and Glycoproteins Research (2 papers), Peptidase Inhibition and Analysis (2 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer therapeutics and mechanisms (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Oncology (639 citations), Biomaterials (327 citations), Pharmacology (187 citations), Pharmaceutical Science (79 citations) and Geriatrics and Gerontology (39 citations). Charity D. Scripture has collaborated with scholars based in United States, Japan and Netherlands. Frequent co-authors include William Douglas Figg, Alex Sparreboom, John A. Pieper, Michael Hawkins, Neil P. Desai, Andrew Jihoon Yang, Tapas Kumar De, Vuong N. Trieu, Paul J. Williams and William L. Dahut. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, Expert Opinion on Drug Metabolism & Toxicology, Lung Cancer and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.